| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |